scholarly journals Investigation of minor psychiatric symptoms in patients with chronic kidney disease on hemodialysis treatment

2018 ◽  
Vol 28 (2) ◽  
pp. 29538
Author(s):  
Caio Henrique Rangel Silva ◽  
Vanessa de Albuquerque Cítero ◽  
Daniel Pereira Coqueiro ◽  
Noemi Peres Honorato
Keyword(s):  
Psychiatric Symptoms ◽  
Age Groups ◽  
Depression Scale ◽  
Cross Sectional Study ◽  
Categorical Variables ◽  
Anxiety And Depression ◽  
Positive Contribution ◽  
Hospital Anxiety ◽  
Psychotherapeutic Treatment ◽  
Cross Sectional

AIMS: To identify the sociodemographic characteristics and the presence of minor symptoms of anxiety and depression in patients on hemodialysis.METHODS: Cross-sectional study, carried out in the hemodialysis units of the Santas Casas de Misericórdia in Marília and Tupã, São Paulo state, Brazil, with 65 hemodialytic patients, ranging from 20 to 86 years. Initially, the mental state of the participants was evaluated in order to ensure they had conditions to understand the research objectives and to respond to the evaluation instruments. Following, the subjects answered to the socio-demographic and clinical questionnaire and the Hospital Anxiety and Depression Scale. The data were organized using relative and absolute frequencies for the categorical variables, and measures of central tendency and dispersion for the quantitative variables. In order to compare the mean scores according to the studied variables, unpaired Student's t test and Analysis of Variance were used in addition to Mann Whitney U-Test and Kruskal-Wallis test when the distribution did not present normality. The adopted level of significance was 5% (p<0.05).RESULTS: The Hospital Anxiety and Depression Scale for minor symptoms identified 42 patients with anxiety and 45 with depression. The anxiety mean scores were statistically higher in the female (10.23±4.51) than in the male (8.32±3.68) patients (p=0.034). Patients aged 31 to 41 years and 42 to 52 years had higher depression scores (12.20±1.48 and 11.16±2.50 respectively) when compared to patients aged over 52 years (9.23±3.63) and aged 20 to 30 years (5.50±2.12) (p=0.017). Patients who underwent psychotherapeutic treatment had lower scores of anxiety (1.00±1.41) compared to those who had already undergone psychotherapeutic treatment and those had never been under treatment (9.27±3.92 and 12.75±3.40 respectively) (p=0.020).CONCLUSIONS: According to the Hospital Anxiety and Depression Scale, women had higher anxiety mean scores than men. The lowest scores for anxiety and depression were present in the younger and older age groups of women, and those who underwent psychotherapy presented even lower scores. Clinical management in psychotherapy can be a positive contribution to ease the symptoms of anxiety and depression, improving the patients' ability to cope with hemodialysis.

scholarly journals Agreement between a single-item measure of anxiety and depression and the Hospital Anxiety and Depression Scale: A cross-sectional study

PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0210111 ◽  
Author(s):  
Heidi Turon ◽  
Mariko Carey ◽  
Allison Boyes ◽  
Bree Hobden ◽  
Sophie Dilworth ◽  
...  
Keyword(s):  
Depression Scale ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Sectional Study ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Single Item

scholarly journals Assessment of anxiety and depression among hospitalized COVID-19 patients in Thailand during the first wave of the pandemic: a cross-sectional study

2021 ◽  
Vol 57 (1) ◽  
Author(s):  
Wajana Thaweerat ◽  
Wannarat Amornnimit Pongpirul ◽  
Wisit Prasithsirikul
Keyword(s):  
Depression Scale ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Sectional Study ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Demographic Difference ◽  
Scale Scores

AbstractAnxiety and depression in hospitalized COVID-19 patients in Thailand during the first wave of the pandemic were investigated. Thai version of Hospital Anxiety and Depression Scale (HADS) was chosen as an instrument for evaluation. Thirty-two voluntary participants completed the questionnaire. Three (9.4%) respondents had abnormal anxiety sub-scale scores while no respondents had abnormal depression sub-scale scores. There was no statistical demographic difference between the anxiety and non-anxiety groups.

scholarly journals Association Between Levels of Depression Symptoms and Moderately Increased Levels of the Inflammation Marker Albuminuria Is Explained by Age and Comorbidity.

2021 ◽  
Author(s):  
Solfrid Romundstad ◽  
Torfinn Hynnekleiv
Keyword(s):  
Depression Scale ◽  
Cross Sectional Study ◽  
Health Study ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Sectional Study ◽  
Inflammation Marker ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Symptoms Of Depression

Abstract Background: The study aimed to examine whether there are associations between levels of depression symptoms and levels of the inflammation marker albuminuria. Materials and methods: The 8303 participants in this cross-sectional study were subjects from the second survey of the Trøndelag Health Study (HUNT, Norway). Depression symptoms were assessed by the Hospital Anxiety and Depression Scale (HADS). Logistic regression analysis was performed to estimate the odds ratio (OR) for moderately increased albuminuria (ACR > 3.0 mg/mmol) according to different HADS subgroups and -scores.Results: Unadjusted ORs for moderately increased albuminuria were significantly increased in those with HADS > 8 (OR 1.27, 95% CI 1.05-1.54, p=0.013) and HADS > 11 (OR 1.59, 95% CI 1.19-2.14, p=0.002). However, after adjusting for age and sex, only HADS > 11 was significantly associated with ACR > 3.0 mg/mmol (OR 1.46, 95% CI 1.08-1.98, p=0.014), and after multivariable adjustments for cardiovascular risk factors and comorbidity, there were no significant associations. Conclusion: The positive and significant association between moderately increased albuminuria and symptoms of depression found in unadjusted analyses weakened and disappeared after adjustments. Although individuals with depressive symptoms had albuminuria more often than individuals without such symptoms, albuminuria may reflect other comorbidity and inflammation conditions than depression.

Gender differences in the well-being of patients diagnosed with Chlamydia trachomatis: a cross-sectional study

2018 ◽  
Vol 94 (6) ◽  
pp. 401-405 ◽  
Author(s):  
Nirina Andersson ◽  
Helena Carré ◽  
Urban Janlert ◽  
Jens Boman ◽  
Elisabet Nylander
Keyword(s):  
Gender Differences ◽  
Chlamydia Trachomatis ◽  
Preventive Measures ◽  
Depression Scale ◽  
Well Being ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Disorder Identification

ObjectivesWe aimed to investigate how an infection with Chlamydia trachomatis (CT) influenced patients’ well-being and whether there were differences due to gender, age or relationship status, in an effort to strengthen preventive measures and provide better healthcare for patients with CT.MethodsPatients diagnosed with CT in the county of Västerbotten, Sweden, were asked to fill out a questionnaire about their feelings, thoughts and actions after CT diagnosis. The patients were also asked to fill in the validated questionnaires Hospital Anxiety and Depression Scale and Alcohol Use Disorder Identification Test. Between February 2015 and January 2017, 128 patients (74 women and 54 men) were included in the study.ResultsAfter being diagnosed with CT, men were generally less worried than women (P<0.001). Women worried more about not being able to have children (P<0.001) and about having other STIs (P=0.001) than men did. Men felt less angry (P=0.001), less bad (P<0.001), less dirty (P<0.001) and less embarrassed (P=0.011) than women did. Nineteen per cent of men and 48% of women reported symptoms of anxiety. The majority of both men (60%) and women (72%) had a risk consumption of alcohol.ConclusionWomen and men reacted differently when diagnosed with CT. Women worried more about complications and more often blamed themselves for being infected. Being aware of these gender differences may be important when planning preventive measures and during counselling of CT-infected patients. Persons working with patients with CT must also be aware of the high frequency of harmful alcohol consumption among their patients.

scholarly journals Cluster headache and anxiety: Results of the EUROLIGHT cluster headache project – An Internet-based, cross-sectional study of people with cluster headache

2020 ◽  
Vol 4 (1) ◽  
pp. 2514183X2092595
Author(s):  
Heiko Pohl ◽  
Andreas R Gantenbein ◽  
Peter S Sandor ◽  
Jean Schoenen ◽  
Colette Andrée
Keyword(s):  
Cluster Headache ◽  
Odds Ratio ◽  
Elevated Level ◽  
Depression Scale ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Sectional Study ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Anxiety Subscale

Objective: The aim of this study is to evaluate how anxiety influences the burden of disease of cluster headache. Methods: Participants completed a modified version of the EUROLIGHT questionnaire. Anxiety was measured with the anxiety subscale of the Hospital Anxiety and Depression scale. An elevated level of anxiety was assumed when eight or more points were scored. Results: The data of 1089 participants were taken for analysis. The score of the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A) correlated weakly with the number of attacks in the last 30 days ( r = 0.17). A score of eight and above in the HADS-A was associated with hurting oneself during an attack (odds ratio (OR) = 2.63), worrying about future attacks (OR = 2.95) and reporting of both failed relationships (OR = 2.81) and career problems (OR = 2.65). The odds of feeling understood by family and friends as well as colleagues and employers were lower in anxious persons (OR = 0.35 and 0.40, respectively). Conclusions: Anxiety complicates dealing with cluster headache and strongly aggravates its burden. Instead of finding help in others, anxious persons feel misunderstood and withdraw; relationships fail and difficulties at work arise.

scholarly journals Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study

2020 ◽  
Author(s):  
Miyabi Uda ◽  
Motomu Hashimoto ◽  
Ryuji Uozumi ◽  
Mie Torii ◽  
Takao Fujii ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Disease Activity ◽  
Depression Scale ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Sectional Study ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Hospital Anxiety Depression Scale ◽  
Anxiety Depression

Abstract Introduction / objectives Management of anxiety and depression in rheumatoid arthritis (RA) patients is vital. Previous studies investigating this topic are conflicting, and this topic still has not been thoroughly investigated. This study aimed to clarify the association of disease activity with anxiety and depression after controlling for physical disability, pain, and treatment. Method We conducted a cross-sectional study of RA patients from the Kyoto University Rheumatoid Arthritis Management Alliance cohort. For assessments, we used the Disease Activity Score (DAS28), Health Assessment Questionnaire Disability Index (HAQ-DI), and Hospital Anxiety Depression Scale. Depression and anxiety were defined by a Hospital Anxiety Depression Scale score ≥8. We then performed multivariable logistic regression analyses. Results Of 517 participants, 17.9% had anxiety, and 28.2% had depression. The multivariable logistic regression analyses showed patients with DAS28-based non-remission had low association with anxiety (odds ratio [OR] [95% confidence interval {CI}], 0.93 [0.48–1.78]: p = 0.82) but slight association with depression (OR [95% CI], 1.45 [0.81–2.61]: p = 0.22). However, severity of the patient’s global assessment (PtGA) on DAS28 was associated with anxiety (OR [95% CI], 1.15 [1.02–1.29]; p = 0.03) and depression (OR [95% CI], 1.21 [1.09–1.35]; p < 0.01). Additionally, HAQ-DI-based non-remission was associated with anxiety (OR [95% CI], 3.51 [1.85–6.64]; p < 0.01) and depression (OR [95% CI], 2.65 [1.56–4.50]; p < 0.01). Younger patients (OR [95% CI], 0.83 [0.68–1.01]; p = 0.07) and patients not treated with methotrexate (OR [95% CI], 0.67 [0.40–1.13]; p = 0.13) tended to suffer from anxiety. Patients using steroids had a closer association with depression than those not using them (OR [95% CI], 1.66 [1.03–2.67]; p = 0.04). Conclusions Assessment of disease activity, PtGA, and HAQ-DI are important for assessing anxiety and depression in RA patients. Attention should be paid to improving PtGA and physical function.

scholarly journals Association between depression and anxiety among the COPD patients in a Nepalese community hospital: a cross sectional study

2020 ◽  
Vol 4 (3) ◽  
pp. 809-812
Author(s):  
Regan Shakya ◽  
Bandana Gautam
Keyword(s):  
Depression Scale ◽  
Cross Sectional Study ◽  
Anxiety Symptoms ◽  
Airflow Limitation ◽  
Anxiety And Depression ◽  
P Value ◽  
Depression And Anxiety ◽  
Sectional Study ◽  
Hospital Anxiety ◽  
Cross Sectional

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a progressive disabling illness characterized by persistent airflow limitation affecting physical, psychological and social aspect of the individual. Amongst the associated co morbidities, depression and anxiety has been identified as common modifiable psychiatric comorbidities of COPD which impacts the patient’s quality of life.  Objectives: To establish the prevalence of depression and anxiety among the COPD patient and determine the association between them. Methodology: The cross sectional study was conducted at Dhulikhel Hospital. We used a convenient sampling method to recruit seventy three COPD participants admitted in the Medicine ward. We interviewed the participants to evaluate anxiety and depression using the Nepali version of Hospital Anxiety and Depression Scale questionnaire. We considered positive result of anxiety and depression when the Hospital Anxiety and Depression score was above eight.  Results: Depressive and Anxiety symptoms were observed in 30 % and 33% of the participants respectively. Similarly 20% of the participants had both the symptoms of depression and anxiety. The association between depression and anxiety was found to be highly significant (p<0.001). In the multivariate model the odds of depression and anxiety was nine percent increase with every one year increase in age after adjusting for gender and duration of illness. (adjusted OR: 1.07; CI 1.00- 1.17; p-value: 0.03). In an unadjusted model depression was significantly associated to every year increase in age (unadjusted OR: 1.07; CI: 1.00- 1.13; p-value: 0.03) Conclusion: Depression and anxiety is prevalent among COPD patient at Dhulikhel hospital with one fifth of the patient demonstrating both depression and anxiety symptoms.

The Prevalence of Anxiety and Depression in Arab Dermatology Patients

2015 ◽  
Vol 19 (3) ◽  
pp. 297-303 ◽  
Author(s):  
Mohammed A. Alshahwan
Keyword(s):  
Depression Scale ◽  
Cross Sectional Study ◽  
Disease Type ◽  
The Other ◽  
University Hospital ◽  
Anxiety And Depression ◽  
Sectional Study ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Dermatology Clinic

Background Psychiatric disorders are common among patients with physical illnesses. Objectives To estimate the prevalence of anxiety and depression in Arab dermatology patients and to study its association with the patients’ characteristics. Materials and Methods A cross-sectional study was carried out on 875 patients attending the Dermatology Clinic at King Khalid University Hospital in Riyadh, Saudi Arabia. Each patient was asked to complete the Hospital Anxiety and Depression Scale and the demographic-clinical questionnaire. Results The frequency of anxiety and depression in Arab dermatology patients was 29% for anxiety and 14% for depression. These frequencies were not related to sociodemographic and clinical variables (p > .05), except skin disease type (p < .05). Patients suffering from hair loss had the highest anxiety and depression scores (OR 1.725 [95% CI 1.247-2.386] and OR 1.686 [95% CI 1.101-2.581], respectively). On the other hand, patients suffering from psoriasis had the highest depression scores (OR 2.909 [95% CI 1.611-5.254]). Conclusion Anxiety and depression are frequent among Arab dermatology patients.

scholarly journals Exploring the factors associated with coronaphobia among physicians during the COVID-19 outbreak in Egypt

2021 ◽  
Vol 57 (1) ◽  
Author(s):  
Mohamed Abdelghani ◽  
Mervat S. Hassan ◽  
Hayam M. Elgohary ◽  
Eman Fouad
Keyword(s):  
Depressive Symptoms ◽  
Virus Infection ◽  
Depression Scale ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Cross Sectional ◽  
Factors Associated ◽  
Death Wishes ◽  
Assessment Measures

Abstract Background Coronaphobia refers to intensified and persistent fears of contracting COVID-19 virus infection. This study aimed to evaluate the newly termed phenomenon, coronaphobia, and address its associated correlates among Egyptian physicians during the outbreak. A cross-sectional study, including a total of 426 Egyptian physicians working during COVID-19 outbreak, was conducted between March 1st and May 1st, 2020. The Fear of COVID-19 Scale (FCV-19S) and Hospital Anxiety and Depression Scale (HADS) were utilized for assessment of coronaphobia, and comorbid anxiety and depressive symptoms among physicians, respectively during the outbreak. Results Moderate-to-severe symptoms of anxiety and depression were reported by 28% and 30% of physicians, respectively. Physicians experiencing higher levels of coronaphobia were more likely to be females, nonsmokers, having death wishes and/or self-harming thoughts, receiving insufficient training, dissatisfied with their personal protective equipment (PPE), and had colleagues infected with COVID-19 virus infection. Coronaphobia was positively correlated with anxiety (r = 0.59, P < 0.001) and depressive symptoms (r = 0.47, P < 0.001). Conclusions Egyptian physicians experienced higher levels of coronaphobia, anxiety, and depressive symptoms during the COVID-19 outbreak. Yet, frontline physicians did not differ from their second-line counterparts regarding the aforementioned symptoms. Routine mental and physical assessment measures of medical staff should be implemented.

Sign in / Sign up

Export Citation Format

Share Document